Meta-analysis of five VEGFA polymorphisms (−2578 A/C: 4,016 cases/4159 controls, −1498 C/T: 1616 cases/1721 controls, −1154 G/A: 3233 cases/3491 controls, −634 G/C: 5060 cases/5306 controls and 936 C/T: 8013 cases/8203 controls) by Wang et al. showed that all five polymorphisms were not associated with risk of breast cancer [84]. The gene discussed is VEGFA; the disease is breast cancer.